(Q38037154)

English

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

scientific article published on August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 August 2017

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42. (English)

1 reference

Europe PubMed Central

27 August 2017

0 references

Alzheimer's disease

0 references

cerebrospinal fluid

0 references

Henrik Zetterberg

28

object named as

Henrik Zetterberg

1 reference

Europe PubMed Central

27 August 2017

29

object named as

Kaj Blennow

1 reference

Europe PubMed Central

27 August 2017

object named as

Josef Pannee

19

0 references

Marinus Blankenstein

object named as

Marinus A Blankenstein

5

0 references

Maria C Carrillo

7

object named as

Maria C Carrillo

1 reference

Europe PubMed Central

27 August 2017

Charlotte Teunissen

24

object named as

Charlotte E Teunissen

1 reference

Europe PubMed Central

27 August 2017

30

object named as

Erik Portelius

1 reference

Europe PubMed Central

27 August 2017

Niklas Mattsson

1

object named as

Niklas Mattsson

1 reference

Europe PubMed Central

27 August 2017

4

object named as

Maria Bjerke

1 reference

Europe PubMed Central

27 August 2017

3

object named as

Ulf Andreasson

1 reference

Europe PubMed Central

27 August 2017

Hugo Vanderstichele

27

object named as

Hugo Vanderstichele

1 reference

Europe PubMed Central

27 August 2017

Michael P T Lunn

16

object named as

Michael P Lunn

1 reference

Europe PubMed Central

27 August 2017

25

object named as

Marcel M Verbeek

1 reference

Europe PubMed Central

27 August 2017

8

object named as

Johan Gobom

1 reference

Europe PubMed Central

27 August 2017

23

object named as

Holly Soares

1 reference

Europe PubMed Central

27 August 2017

Andreas Jeromin

11

object named as

Andreas Jeromin

1 reference

Europe PubMed Central

27 August 2017

13

object named as

Daniel Kidd

1 reference

Europe PubMed Central

27 August 2017

26

object named as

Robert M Umek

1 reference

Europe PubMed Central

27 August 2017

2

object named as

Ingrid Zegers

1 reference

Europe PubMed Central

27 August 2017

6

object named as

Robert Bowser

1 reference

Europe PubMed Central

27 August 2017

10

object named as

Rand Jenkins

1 reference

Europe PubMed Central

27 August 2017

14

object named as

Omar F Laterza

1 reference

Europe PubMed Central

27 August 2017

author name string

Theresa Heath

9

1 reference

Europe PubMed Central

27 August 2017

June Kaplow

12

1 reference

Europe PubMed Central

27 August 2017

Andrew Lockhart

15

1 reference

Europe PubMed Central

27 August 2017

Robert L Martone

17

1 reference

Europe PubMed Central

27 August 2017

Kevin Mills

18

1 reference

Europe PubMed Central

27 August 2017

Marianne Ratcliffe

20

1 reference

Europe PubMed Central

27 August 2017

Leslie M Shaw

21

1 reference

Europe PubMed Central

27 August 2017

Adam J Simon

22

1 reference

Europe PubMed Central

27 August 2017

publication date

1 August 2012

1 reference

Europe PubMed Central

27 August 2017

Biomarkers in Medicine

1 reference

Europe PubMed Central

27 August 2017

6

1 reference

Europe PubMed Central

27 August 2017

4

1 reference

Europe PubMed Central

27 August 2017

409-417

1 reference

Europe PubMed Central

27 August 2017

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Revising the definition of Alzheimer's disease: a new lexicon.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Association study of clusterin polymorphism rs11136000 with late onset Alzheimer's disease in Chinese Han population

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

International quality control survey of neurochemical dementia diagnostics.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

High education may offer protection against tauopathy in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Standardizing plasma protein measurements worldwide: a challenging enterprise

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

The importance of metrological traceability on the validity of creatinine measurement as an index of renal function.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Standardization in clinical enzymology: a challenge for the theory of metrological traceability

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Traceability of values for catalytic activity concentration of enzymes: a Certified Reference Material for aspartate transaminase.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Protein standardization IV: Value transfer procedure for the assignment of serum protein values from a reference preparation to a target material.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Reference measurement procedure development for C-reactive protein in human serum.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Toward Système International d'Unité-traceable protein quantification: from amino acids to proteins.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

The IFCC Reference Measurement System for HbA1c: a 6-year progress report.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Approved IFCC reference method for the measurement of HbA1c in human blood

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Analytical aspects of molecular Alzheimer's disease biomarkers

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Development and evaluation of a candidate reference measurement procedure for the determination of testosterone in human serum using isotope dilution liquid chromatography/tandem mass spectrometry.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Solid-phase extraction enhances detection of beta-amyloid peptides in plasma and enables Abeta quantification following passive immunization with Abeta antibodies

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

LC-MS/MS for protein and peptide quantification in clinical chemistry

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Quantitation of amyloid beta peptides Aβ(1-38), Aβ(1-40), and Aβ(1-42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Characterization of tau in cerebrospinal fluid using mass spectrometry.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Characterization of the New Serum Protein Reference Material ERM-DA470k/IFCC: Value Assignment by Immunoassay

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Identifiers

10.2217/BMM.12.39

1 reference

Europe PubMed Central

27 August 2017

1 reference

Europe PubMed Central

27 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38037154&oldid=1857630395"